For example, in vitro and in vivo studies have consistently showed that IGU could effectively protect against cancer-induced bone pain and bone destruction, probably via downregulating interleukin-6 production in a nuclear factor-κB-dependent manner [54, 55]. This evidence concerns the gene IL6 and cancer.